C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/06 (2006.01) A61K 31/522 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2596612
A class of novel antagonists for the adenosine A3 receptor are disclosed. These compounds are useful as therapeutic agents for a number of diseases and medical conditions that are mediated by the A3 receptor. The compounds of this invention are also useful as diagnostic agents for the A3 receptor.
La présente invention concerne une classe de nouveaux antagonistes du récepteur A3 d'adénosine. Ces composés conviennent comme agents thérapeutiques pour un certain nombre de maladies et de pathologie médicale induite par le récepteur A3. Le composé de sept inventions convienne aussi comme agents de diagnostic du récepteur A3.
Baraldi Pier Giovanni
Borea Pier Andrea
Preti Delia
Tabrizi Mojgan Aghazadeh
King Pharmaceuticals Research And Development Inc.
Smart & Biggar
LandOfFree
Novel adenosine a3 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel adenosine a3 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel adenosine a3 receptor modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1401109